Evonik’s Stock Teeters Near 52-Week Low as Analysts Slash Ratings
Evonik Stock: Critical Level at Risk
Evonik stock nears 52-week low after analysts cut valuation and express concerns about dividend coverage. Technical chart remains extremely tense.
2025-12-06T01:30:18+00:00
finance, investing, stock-market
Evonik’s stock has fallen close to its lowest point in a year. Analysts have cut their ratings, warning about weak dividend coverage and cash flow risks. The shares are now trading just above €12.83, a level that could trigger further declines if breached.
The company’s stock has faced growing pressure after two major downgrades. JPMorgan shifted its rating to Neutral, highlighting concerns over dividend sustainability from free cash flow. Kepler Cheuvreux went further, lowering its recommendation from Hold to Reduce and slashing the price target to €12.60.
With shares hovering near their 52-week low, another drop could worsen the bearish outlook. The gap between the current price and the 200-day average suggests a steep climb would be needed for any meaningful rebound. Analysts’ warnings about dividend risks add to the challenges ahead.
Read also:
- India's Agriculture Minister Reviews Sector Progress Amid Heavy Rains, Crop Areas Up
- Cyprus, Kuwait Strengthen Strategic Partnership with Upcoming Ministerial Meeting
- Inspired & Paddy Power Extend Virtual Sports Partnership for UK & Ireland Retail
- South West & South East England: Check & Object to Lorry Operator Licensing Now
